Cystinosis Global Clinical Trials Review, H1, 2019

GlobalData's clinical trial report, “Cystinosis Global Clinical Trials Review, H1, 2019" provides an overview of Cystinosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cystinosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Horizon Pharma Plc

Eloxx Pharmaceuticals Inc

Syneos Health Inc

Sigma-Tau SpA

Raptor Therapeutics Inc

Raptor Pharmaceutical Corp (Inactive)

ICON Plc

Ergomed Plc

Celerion Inc

Horizon Pharma Plc

Eloxx Pharmaceuticals Inc

Syneos Health Inc

Sigma-Tau SpA

Raptor Therapeutics Inc

Raptor Pharmaceutical Corp (Inactive)

ICON Plc

Ergomed Plc

Celerion Inc

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region ...

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Central and South America 13

Clinical Trials by G7 Countries: Proportion of Cystinosis to Genetic Disorders Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Cystinosis to Genetic Disorders Clinical Trials 17

Clinical Trials by Phase 18

Clinical Trials by Trial Status 19

Clinical Trials by End Point Status 20

Clinical Trials by Sponsor Type 21

Prominent Sponsors 22

Top Companies Participating in Cystinosis Therapeutics Clinical Trials 24

Prominent Drugs 26

Clinical Trial Profile Snapshots 27

Appendix 39

Abbreviations 39

Definitions 39

Research Methodology 40

Secondary Research 40

About GlobalData 41

Contact Us 41

Source 42

List of Tables

Cystinosis Therapeutics, Global, Clinical Trials by Region, 2019* 7

Cystinosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8

Cystinosis Therapeutics, Global ...

Cystinosis Therapeutics, Global, Clinical Trials by Region, 2019* 7

Cystinosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8

Cystinosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Cystinosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 11

Cystinosis Therapeutics Clinical Trials, North America, Top Countries, 2019* 12

Cystinosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 13

Proportion of Cystinosis to Genetic Disorders Clinical Trials, G7 Countries (%), 2019* 14

Cystinosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 15

Cystinosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 16

Proportion of Cystinosis to Genetic Disorders Clinical Trials, E7 Countries (%), 2019* 17

Cystinosis Therapeutics, Global, Clinical Trials by Phase, 2019* 18

Cystinosis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 19

Cystinosis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 20

Cystinosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 21

Cystinosis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 22

Cystinosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 24

Cystinosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 26

List of Figures

Cystinosis Therapeutics, Global, Clinical Trials by Region (%), 2019* 7

Cystinosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8

Cystinosis Therapeutics, Global ...

Cystinosis Therapeutics, Global, Clinical Trials by Region (%), 2019* 7

Cystinosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8

Cystinosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Cystinosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 11

Proportion of Cystinosis to Genetic Disorders Clinical Trials, G7 Countries (%), 2019* 14

Cystinosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 15

Cystinosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 16

Proportion of Cystinosis to Genetic Disorders Clinical Trials, E7 Countries (%), 2019* 17

Cystinosis Therapeutics, Global, Clinical Trials by Phase (%), 2019* 18

Cystinosis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 19

Cystinosis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 20

Cystinosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 21

Cystinosis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 22

Cystinosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 24

Cystinosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 26

GlobalData Methodology 40

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports